Semarion will join the Milner Therapeutics Symposium 2020 on June 26th to speak about revolutionizing cell-based assays using SemaCyte microcarriers. We will be pitching alongside other Cambridge-based biotech startups. Meet us at the event!
Session: Investment & start-ups in Cambridge: June 26th, live Q&A 1pm
An opportunity to hear from Jason Mellad (CEO, Start Codon) about this new healthcare accelerator. This session will include short talks from the first cohort of companies in the programme focusing on:
- gene therapy for rare and complex diseases
- next generation antibody drug conjugates with higher DAR and therapeutic index
- novel magnetic microcarriers for miniaturising and multiplexing cellular assays
- functional genomics that unlocks the non-coding genome to discover new drug targets and diagnostic biomarkers